Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Martin Aringer Britta Siegmund |
| Publication date | July 12, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |